RankAlpha logo
Back to Rankings

IRD

Opus GeneticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Successful clinical/data milestones or a strategic partnership/licensing deal could materially re-rate the stock, validating platform potential and improving near-term financing prospects.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Clinical trial failure or negative data readout
Momentum
28
Value
41
Sentiment
4
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.82 · Bull $2.91 · Bear $0.91Analysis 2025-09-29; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-28 • Model: HYBRID_IC_RP
AI Memo
As of 2025-09-29 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-10-28

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-28. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $13.47
Why
Momentum28 · Δ7d -20.0
Value41 · Δ7d -0.1
Sentiment4 · Δ7d +6.5
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • • Value remains the lead driver in the composite, 7D delta -0.1.

Contradictions & invalidation

  • • Clinical trial failure or negative data readout
  • • Inability to raise non-dilutive capital or adverse financing terms
  • • Clinical setbacks, inability to secure non-dilutive financing, or persistent low liquidity could drive further downside and shareholder dilution.

Catalyst clock

No dated catalyst is available.

Lead driver: Value · See fundamentals
Momentum
28
8% active weight
Current posture
7d trendFlat
Δ7d
-20.0
Δ21d
-74.4
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.3
Sentiment
4
45% active weight
Current posture
7d trendImproving
Δ7d
+6.5
Δ21d
+6.5
Why this grade

Composite grade F. Momentum 28.2 / Value 40.6 / Sentiment 4.1

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-09-29. Scenario method

B+
Bull case
20%
Probability
Target price
$2.91
Analysis reference price unavailable
Analysis 2025-09-29 · RankAlpha Sentiment AI
Most likely
B
Base case
60%
Probability
Target price
$1.82
Analysis reference price unavailable
Analysis 2025-09-29 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$0.91
Analysis reference price unavailable
Analysis 2025-09-29 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$287.86M
Beta
0.58
Shares Out
83.2M
P/E (TTM) · Derived
-4.3
P/S (TTM)
10.04
P/FCF (TTM) · Derived
-7.18
Rev YoY
-73.8%
EPS YoY
+18.7%
Gross Margin
+99.5%
Op Margin
-513.5%
Net Debt
-$43.96M
Current Ratio
12.19
As of 2026-10-28 • Updated nightlySource: Internal modelMethods & Data